Skye Bioscience Insider Selling Frenzy: 1.4 Million Shares Off the Books Amid Reverse Split and Pending Redx Pharma Deal
Insider sales flood Skye Bioscience ahead of a reverse split and pending Redx Pharma deal – a red flag for investors amid sharp price swings.
4 minutes to read